LifeMD, Inc.
NASDAQ:LFMD
5.28 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 152.547 | 119.034 | 92.876 | 37.294 | 12.469 | 8.324 | 5.055 | 5.239 | 1.219 | 0.714 | 0.808 | 0.674 | 0.744 |
| Cost of Revenue
| 26.533 | 18.668 | 17.995 | 8.907 | 3.271 | 1.969 | 1.484 | 1.946 | 0.248 | 0.173 | 0.181 | 0.126 | 0.241 |
| Gross Profit
| 126.014 | 100.365 | 74.88 | 28.386 | 9.198 | 6.355 | 3.571 | 3.293 | 0.971 | 0.541 | 0.627 | 0.548 | 0.503 |
| Gross Profit Ratio
| 0.826 | 0.843 | 0.806 | 0.761 | 0.738 | 0.763 | 0.706 | 0.629 | 0.797 | 0.758 | 0.776 | 0.814 | 0.676 |
| Reseach & Development Expenses
| 6.061 | 2.97 | 0.779 | 0.447 | 0.223 | 0.121 | 0 | 0 | 0.024 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 51.694 | 46.961 | 39.57 | 42.207 | 2.399 | 3.331 | 2.981 | 2.757 | 0.979 | 1.072 | 1.173 | 1.088 | 1.079 |
| Selling & Marketing Expenses
| 76.451 | 78.369 | 82.542 | 41.669 | 8.171 | 5.08 | 1.657 | 1.71 | 0.231 | 0.057 | 0 | 0 | 0 |
| SG&A
| 128.146 | 125.33 | 122.112 | 83.876 | 10.57 | 8.411 | 4.639 | 4.467 | 1.209 | 1.072 | 1.173 | 1.088 | 1.079 |
| Other Expenses
| -6.297 | 11.751 | 6.291 | 1.883 | 1.295 | -0.517 | 0.215 | 0 | 0 | 0.058 | 0.054 | 0.081 | 0.078 |
| Operating Expenses
| 140.504 | 140.052 | 129.181 | 86.206 | 12.088 | 8.411 | 4.639 | 4.467 | 1.233 | 1.072 | 1.173 | 1.088 | 1.079 |
| Operating Income
| -14.489 | -39.686 | -54.301 | -57.819 | -2.89 | -2.056 | -1.068 | -1.175 | -0.262 | -0.531 | -0.546 | -0.54 | -0.576 |
| Operating Income Ratio
| -0.095 | -0.333 | -0.585 | -1.55 | -0.232 | -0.247 | -0.211 | -0.224 | -0.215 | -0.743 | -0.676 | -0.801 | -0.775 |
| Total Other Income Expenses Net
| -2.922 | -4.974 | -7.015 | -2.582 | -0.761 | 0.571 | -0.05 | -0.049 | 0.127 | 0.058 | 0.264 | 0.081 | 0.078 |
| Income Before Tax
| -17.411 | -44.66 | -61.316 | -60.402 | -3.651 | -1.485 | -1.218 | -1.223 | -0.172 | -0.478 | -0.285 | -0.463 | -0.52 |
| Income Before Tax Ratio
| -0.114 | -0.375 | -0.66 | -1.62 | -0.293 | -0.178 | -0.241 | -0.234 | -0.141 | -0.669 | -0.353 | -0.687 | -0.699 |
| Income Tax Expense
| 0.428 | 0.361 | 0.008 | 0.123 | -0.123 | -0.125 | -0.012 | -0.116 | -0.013 | -0.017 | -0.017 | -0.017 | -0.017 |
| Net Income
| -20.596 | -45.021 | -61.324 | -60.524 | -3.528 | -1.241 | -1.206 | -1.108 | -0.062 | -0.46 | -0.268 | -0.446 | -0.503 |
| Net Income Ratio
| -0.135 | -0.378 | -0.66 | -1.623 | -0.283 | -0.149 | -0.239 | -0.211 | -0.051 | -0.645 | -0.332 | -0.661 | -0.676 |
| EPS
| -0.61 | -1.45 | -2.27 | -4.24 | -0.36 | -0.14 | -0.14 | -0.16 | -0.01 | -0.076 | -0.046 | -0.081 | -0.067 |
| EPS Diluted
| -0.61 | -1.45 | -2.27 | -4.24 | -0.36 | -0.14 | -0.14 | -0.16 | -0.01 | -0.075 | -0.045 | -0.077 | -0.067 |
| EBITDA
| -7.889 | -32.218 | -49.437 | -57.819 | -2.554 | -0.935 | -1.068 | -1.175 | -0.218 | -0.474 | -0.489 | -0.483 | -0.52 |
| EBITDA Ratio
| -0.052 | -0.271 | -0.532 | -1.55 | -0.205 | -0.112 | -0.211 | -0.224 | -0.179 | -0.664 | -0.605 | -0.717 | -0.699 |